From the July 2022 issue of HealthCare Business News magazine
Looking into the horizon, new technologies under development, such as advanced artificial intelligence (AI), have the potential to provide improved screening performance, and may address the problem of varying levels of diagnostic care by acting as an “expert” reader. This improvement will only be successful if access to AI is not economically restricted. Furthermore, it is incumbent upon medical device companies to ensure that their AI algorithms are properly tested and validated in a diverse population that represents the heterogenous nature of the United States.
Taken altogether, we can help reduce disparities in breast cancer care. We must argue for more widespread access to state-of-the-art breast imaging technologies. MedTech companies must validate their technologies to reflect the racial and ethnical diversity of the U.S. population. And perhaps most importantly, we must educate our families, friends and communities to “go get their mammograms”. This is especially important for those groups who historically have placed lower importance on regular mammography. Any mammogram is better than no mammogram.
Ad Statistics
Times Displayed: 137680
Times Visited: 7952 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About the authors: Paola Wisner is vice president of global research and development at Hologic, and Andy Smith, Ph.D., is vice president of image research breast health at Hologic.
Back to HCB News
